Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
XLVvsFTXHETF Comparison
State Street Health Care Select Sector SPDR ETF (XLV) and First Trust Nasdaq Pharmaceuticals ETF (FTXH) belong to the same industry segment: US Health Care. Both ETFs have the same top 3 sector exposures: and Health Care. XLV is less expensive with a Total Expense Ratio (TER) of 0.08%, versus 0.6% for FTXH. XLV is down -2.96% year-to-date (YTD) with +$900M in YTD flows. FTXH performs better with 2.6% YTD performance, and +$7M in YTD flows. Run a side-by-side ETF comparison of XLV and FTXH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
XLV vs FTXH performance and flow charts
Performance
Cumulative Flows
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | XLV FTXH | -3.74%-2.89% | -2.07%+3.86% | -2.96%+2.60% | +5.69%+22.74% | +25.97%+39.72% | +41.91%+37.82% |
| Flows | XLV FTXH | -$710M+$4M | -$28M+$9M | +$900M+$7M | -$38M+$10M | -$4.95B-$13M | +$6.87B+$7M |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | XLV FTXH | +14.03%+15.86% | +17.46%+20.64% | +13.62%+15.91% | +14.49%+15.69% |
| Max drawdown | XLV FTXH | -6.25%-5.21% | -12.43%-16.42% | -17.05%-19.32% | -17.05%-19.32% |
| Max drawdown duration | XLV FTXH | 11d11d | 211d165d | 444d393d | 444d393d |
XLV | FTXH | |
Last sale 3/13/2026 at 1:30 PM | $149.79 | $33.63 |
| Previous close 03/12/2026 | $150.16 | $33.78 |
| Consolidated volume 03/12/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
XLV | FTXH | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
XLV | FTXH | |
|---|---|---|
| Last price | $149.79 | $33.63 |
| 1D performance | -0.25% | -0.46% |
| AuM | $39.37 B | $28.72 M |
| E/R | 0.08% | 0.6% |
XLV | FTXH | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | SPDR | First Trust |
| Benchmark | S&P Health Care Select Sector Index | NASDAQ US Smart Pharmaceuticals Index |
| N° of holdings | 57 | 49 |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | December 16, 1998 | September 20, 2016 |
| ESG | No | No |
Countries
Sectors
Diversification
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
Top 15 holdings
How have the XLV and FTXH ETFs performed in 2026?
As of March 12, 2026, XLV is down -2.96% year-to-date (YTD), while FTXH has returned 2.6%. That puts FTXH better performer ahead so far this year.
Which ETF is attracting more investor money: XLV or FTXH?
Year-to-date, the XLV ETF saw +$900M in flows, compared to +$7M for FTXH.
Which ETF is more volatile: XLV or FTXH?
Over the past year, XLV had a volatility of 17.46%, while FTXH experienced 20.64%.
Which ETF is bigger: XLV or FTXH?
As of March 12, 2026, XLV holds $39.37 B in assets under management (AUM), while FTXH manages $28.72 M.
What sectors do the XLV and FTXH ETFs invest in?
XLV leans toward sectors like Health Care. Meanwhile, FTXH focuses on Health Care.
What are the top holdings of the XLV ETF and FTXH ETF?
XLV top holdings include LILLY, JOHNSON&JOHNSON and ABBVIE. FTXH holds in its top three: MERCK & CO INC, JOHNSON&JOHNSON and BRISTOL-MYERS SQUIBB.
Which ETF is more diversified: XLV or FTXH?
XLV holds 60 securities with 70.12% of its assets in the top 15. FTXH has 50 securities and a top 15 weight of 71.63%.
ETF Central's Guide to Defensive Sector Investing
Chinese Artificial Intelligence (AI) DeepSeek: ETF Winners & Losers
Investing in Sector ETFs: Consumer Staples, Healthcare, & Utilities
Healthcare Stocks Drop on Medicare Payment Rate Surprise
Health Care Sector Down After a Cyberattack on UnitedHealth
Calamos Investments Powers the Next Phase of the Autocallable Revolution
Join J.P. Morgan’s Bram Kaplan, Head of Americas Equity Derivatives Strategy and Matt Kaufman from Calamos Investments as they dive into the growing global opportunity in autocallable income—an increasingly dominant strategy within structured products, now available through ETFs.
Accepted for 1 CE Credit
